| CTRI Number |
CTRI/2023/06/053597 [Registered on: 06/06/2023] Trial Registered Prospectively |
| Last Modified On: |
05/06/2023 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparison of nerves block in female patients |
|
Scientific Title of Study
|
A comparison between modified thoracoabdominal nerves block through perichondrial approach versus laparoscopic assisted transversus abdominis plane block for quality of recovery in patients undergoing gynaecological laparoscopic surgery: A Prospective Randomized Control Trials |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
T Revanth prasad |
| Designation |
Junior resident |
| Affiliation |
Indira Gandhi Institute of Medical Sciences |
| Address |
Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna,Bihar. Sheikhpura,Patna,Bihar Patna BIHAR 800014 India |
| Phone |
9441116915 |
| Fax |
|
| Email |
revanthprasad131@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Swati |
| Designation |
Additional Professor |
| Affiliation |
Indira Gandhi Institute of Medical Sciences |
| Address |
Indira Gandhi Institute of Medical Sciences,Sheikhpura,Patna,Bihar Sheikhpura,Patna,Bihar Patna BIHAR 800014 India |
| Phone |
8544413241 |
| Fax |
|
| Email |
swatipgi2006@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Swati |
| Designation |
Additional Professor |
| Affiliation |
Indira Gandhi Institute of Medical Sciences |
| Address |
Indira Gandhi Institute of Medical Sciences,Sheikhpura,Patna,Bihar Sheikhpura,Patna,Bihar Patna BIHAR 800014 India |
| Phone |
8544413241 |
| Fax |
|
| Email |
swatipgi2006@gmail.com |
|
|
Source of Monetary or Material Support
|
| Indira Gandhi institute of Medical sciences,Patna |
|
|
Primary Sponsor
|
| Name |
T Revanth Prasad |
| Address |
Department of Anaesthesiology and CCM
1st floor,OT complex,
Indira Gandhi institute of
Medical sciences,[IGIMS],Patna
|
| Type of Sponsor |
Other [[self]] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| T Revanth prasad |
Indira Gandhi Institute of Medical Sciences |
Department of
Anaesthesiology and CCM,
1st floor, OT complex Patna BIHAR |
9441116915
revanthprasad131@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Laparoscopic assisted transversus abdominis plane[TAP] block |
In this block,for patients with disease [fibroids and endometriosis] undergoing gynaecological laparoscopic surgery,20-25 ml of 0.25% of bupivacaine with epinephrine given during end of surgery. |
| Intervention |
Modified Thoraco abdominal nerves block through perichondrial approach |
In this block, patients with disease [fibroids and endometriosis] undergoing gynaecological laparoscopic surgery,25ml of 0.25% ropivacaine given during end of surgery |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Female |
| Details |
1.Age between 18 and 5O years
2.American society of Anesthesiologists [ASA]
physical status I to III
3.Body mass index between 18 and 35 kg/m2
4.Undergoing gyanecological [fibroid/endometriosis]
laparoscopic surgery |
|
| ExclusionCriteria |
| Details |
1.Inability to consent to the study
2.Coagulopathy
3.Sepsis
4.Hepatic or Renal failure
5.Allergy to local anesthetic [LA]
6.Opioid intake at home |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Quality of recovery assessed using the Quality of recovery-15 [QoR-15] scale |
All parameters will be recorded 24 hours postoperatively |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1.Static [at rest] & dynamic
[with movement] pain scores
and [Numeric rating scale
score 1-10]
2.Performance time
[the temporal interval
between the start of skin
disinfection and the end of
Local anesthetic injection
through the block needle]
3.The block related adverse
events [ vascular puncture,
paresthesia,local anesthetic
toxicity]
|
All parameters recorded post operatively at 3,6,12,24 hours |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
19/06/2023 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
Plan to publish after thesis completion |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
We will evalaute the postoperative pain relief using two different techniques for laparoscopic gynaecological surgeries. The MTAPA block will be given in one group and laparoscopic assisted TAP block will be given to the other group. The primary outcome of the study will be Quality of recovery score -15 (QoR-15) at 24 hour postoperatively. |